Dana Doheny

1.5k total citations
21 papers, 846 citations indexed

About

Dana Doheny is a scholar working on Physiology, Neurology and Rheumatology. According to data from OpenAlex, Dana Doheny has authored 21 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Neurology and 5 papers in Rheumatology. Recurrent topics in Dana Doheny's work include Lysosomal Storage Disorders Research (8 papers), Neurological disorders and treatments (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Dana Doheny is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Neurological disorders and treatments (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Dana Doheny collaborates with scholars based in United States, Germany and Italy. Dana Doheny's co-authors include Robert J. Desnick, Makiko Yasuda, Brenden Chen, Laurie J. Ozelius, Susan Bressman, Christine Klein, Mitchell F. Brin, Ram Srinivasan, Inga Peter and Manisha Balwani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Annals of Neurology.

In The Last Decade

Dana Doheny

21 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Doheny United States 13 341 296 260 218 137 21 846
Mauro Scarpelli Italy 17 94 0.3× 535 1.8× 85 0.3× 99 0.5× 179 1.3× 34 796
V. E. Sutliff United States 15 187 0.5× 261 0.9× 256 1.0× 48 0.2× 59 0.4× 23 830
Salvatore Di Mauro United States 10 134 0.4× 455 1.5× 69 0.3× 68 0.3× 94 0.7× 25 743
Iris Marquardt Germany 11 99 0.3× 347 1.2× 50 0.2× 149 0.7× 120 0.9× 15 796
Marie Bojsen‐Møller Denmark 13 183 0.5× 304 1.0× 68 0.3× 20 0.1× 365 2.7× 25 733
Alice Todeschini Italy 12 79 0.2× 255 0.9× 74 0.3× 55 0.3× 101 0.7× 21 525
Foudil Lamari France 14 109 0.3× 257 0.9× 80 0.3× 31 0.1× 227 1.7× 28 582
Christoph Korenke Germany 14 195 0.6× 343 1.2× 28 0.1× 112 0.5× 178 1.3× 21 757
Emma Footitt United Kingdom 17 40 0.1× 387 1.3× 42 0.2× 151 0.7× 92 0.7× 29 735
M S Patel United States 18 53 0.2× 304 1.0× 101 0.4× 28 0.1× 244 1.8× 27 825

Countries citing papers authored by Dana Doheny

Since Specialization
Citations

This map shows the geographic impact of Dana Doheny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Doheny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Doheny more than expected).

Fields of papers citing papers by Dana Doheny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Doheny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Doheny. The network helps show where Dana Doheny may publish in the future.

Co-authorship network of co-authors of Dana Doheny

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Doheny. A scholar is included among the top collaborators of Dana Doheny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Doheny. Dana Doheny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doheny, Dana, et al.. (2018). Many pitfalls in diagnosis of acute intermittent porphyria: a case report. BMC Research Notes. 11(1). 552–552. 7 indexed citations
2.
Doheny, Dana, Ram Srinivasan, Silvère Pagant, et al.. (2018). Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995–2017. Journal of Medical Genetics. 55(4). 261–268. 89 indexed citations
3.
Frustaci, Andrea, Cristina Chimenti, Dana Doheny, & Robert J. Desnick. (2017). Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy. International Journal of Cardiology. 248. 257–262. 16 indexed citations
4.
Desnick, Robert J., et al.. (2017). The Fabry disease genotype-phenotype database (dbFGP): an international expert consortium. Molecular Genetics and Metabolism. 120(1-2). S41–S42. 10 indexed citations
5.
Doheny, Dana, Ram Srinivasan, & Robert J. Desnick. (2017). Fabry disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac, and stroke clinics. Molecular Genetics and Metabolism. 120(1-2). S42–S42. 18 indexed citations
6.
Balwani, Manisha, Preeti Singh, Anju Seth, et al.. (2016). Acute Intermittent Porphyria in children: A case report and review of the literature. Molecular Genetics and Metabolism. 119(4). 295–299. 24 indexed citations
7.
Chen, Brenden, Jörg Hakenberg, Wanqiong Qiao, et al.. (2016). Acute Intermittent Porphyria: Predicted Pathogenicity ofHMBSVariants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease. Human Mutation. 37(11). 1215–1222. 126 indexed citations
8.
Atherton, Andrea M., Dana Doheny, Dawn Peck, et al.. (2015). Newborn screening for Fabry disease: Is the A143T allele a pathogenic mutation or a pseudodeficiency allele?. Molecular Genetics and Metabolism. 114(2). S14–S15. 1 indexed citations
9.
Desnick, Robert J., Dana Doheny, Brenden Chen, et al.. (2015). Fabry disease: The α-galactosidase A (GLA) c.427G>A (A143T) mutation, effect of the 5′-10C>T polymorphism. Molecular Genetics and Metabolism. 114(2). S37–S37. 7 indexed citations
10.
11.
12.
Dobrovolný, Robert, Irina Nazarenko, Jung‐Min Kim, Dana Doheny, & Robert J. Desnick. (2011). Detection of large gene rearrangements in X-linked genes by dosage analysis: identification of novel α-galactosidase A (GLA) deletions causing Fabry disease. Human Mutation. 32(6). 688–695. 12 indexed citations
13.
Peter, Inga, Adele A. Mitchell, Laurie J. Ozelius, et al.. (2011). Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study. BMC Medical Genetics. 12(1). 63–63. 38 indexed citations
14.
Lubitz, Steven A., Stuart A. Scott, Inga Peter, et al.. (2010). Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population. Journal of Thrombosis and Haemostasis. 8(5). 1018–1026. 47 indexed citations
15.
Raymond, Deborah, Rachel Saunders‐Pullman, Patrícia de Carvalho Aguiar, et al.. (2008). Phenotypic spectrum and sex effects in eleven myoclonus‐dystonia families with ε‐sarcoglycan mutations. Movement Disorders. 23(4). 588–592. 35 indexed citations
16.
Hernández, Dena, Melissa Hanson, Amanda Singleton, et al.. (2003). Mutation at the SCA17 locus is not a common cause of parkinsonism. Parkinsonism & Related Disorders. 9(6). 317–320. 11 indexed citations
17.
Klein, Christine, Liu Liu, Dana Doheny, et al.. (2002). ε‐sarcoglycan mutations found in combination with other dystonia gene mutations. Annals of Neurology. 52(5). 675–679. 69 indexed citations
18.
Doheny, Dana, Fabio Danisi, Christopher J. Smith, et al.. (2002). Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology. 59(8). 1244–1246. 44 indexed citations
19.
Leung, Joanne, Christine Klein, Jennifer Friedman, et al.. (2001). Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics. 3(3). 133–143. 126 indexed citations
20.
Klein, Christine, Mitchell F. Brin, Patricia Kramer, et al.. (1999). Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proceedings of the National Academy of Sciences. 96(9). 5173–5176. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Scarpelli Breakdown of academic impact, for papers by V. E. Sutliff Breakdown of academic impact, for papers by Salvatore Di Mauro Breakdown of academic impact, for papers by Iris Marquardt Breakdown of academic impact, for papers by Marie Bojsen‐Møller Breakdown of academic impact, for papers by Alice Todeschini Breakdown of academic impact, for papers by Foudil Lamari Breakdown of academic impact, for papers by Christoph Korenke Breakdown of academic impact, for papers by Emma Footitt Breakdown of academic impact, for papers by M S Patel
Rankless by CCL
2026